Form 4: Anika Therapeutics SVP Anne Nunes Reports Stock Transactions
SEC Form 4 Filing
Anne Nunes, SVP and Chief Operations Officer of Anika Therapeutics, reports the vesting of restricted stock units and shares withheld for tax obligations.
Summary
- Anne Nunes, SVP, Chief Operations Officer of Anika Therapeutics, filed a Form 4.
- On March 10, 2025, Nunes vested 3,296 shares of common stock from Restricted Stock Units (RSUs).
- 959 shares of common stock were withheld by the issuer to satisfy tax obligations related to the RSU vesting at a price of $16.62.
- Nunes also acquired 460 shares under the Employee Stock Purchase Plan on November 14, 2024.
- Following these transactions, Nunes directly owns 16,276 shares of Anika Therapeutics common stock and 3,295 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations.
Positives
- The vesting of RSUs indicates a continued investment in the company by a key executive.
- Participation in the Employee Stock Purchase Plan demonstrates confidence in the company's future.
Industry Context
Form 4 filings are a routine part of compliance for corporate insiders and provide transparency into their transactions in company stock. This filing indicates normal compensation and tax-related activities.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders as they are part of standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| March 9, 2023 | Date of grant for the RSUs, vesting in three equal annual installments. |
| March 9, 2024 | First vesting installment of RSUs. |
| November 14, 2024 | Date of purchase of 460 shares under the Employee Stock Purchase Plan. |
| March 7, 2025 | Trading day prior to RSU vesting, closing price of ANIK common stock was $16.62. |
| March 9, 2025 | Second vesting installment of RSUs. |
| March 10, 2025 | Date of transaction: vesting of RSUs and withholding of shares for taxes. |
| March 11, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.